In-vivo activity and tolerance of conventional formulation versus fat emulsion formulation of amphotericin B in experimental disseminated candidiasis in neutropenic rabbits

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 3, 1997, Pages 427-430

  Chavanet, Pascal ^a   Duong, Michel ^a   Buisson, Marielle ^a   Hamel, Hélène ^a   Dubois, Claudine ^a   Bonnin, Alain ^a   Portier, Henri ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; GLUCOSE; INTRALIPID; LIPID EMULSION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDIASIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERANCE; GRANULOCYTOPENIA; MALE; NONHUMAN; RABBIT;

AMPHOTERICIN B; ANIMALS; CANDIDIASIS; CREATININE; FAT EMULSIONS, INTRAVENOUS; GLUCOSE; KIDNEY; MALE; NEUTROPENIA; RABBITS; UREA;

EID: 0030973790     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.3.427     Document Type: Article

References (11)

1. Kirsh, R., Goldstein, R., Tarloff, J., Parris, D., Hook, J., Hanna, N. et al. (1988). An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. Journal of Infectious Diseases 158, 1065-70.
2. Moreau, P., Milpied, N., Fayette, N., Ramée, J. F. & Harousseau, J. L. (1992). Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with Intralipid compared with conventional amphotericin B in neutropenic patients. Journal of Antimicrobial Chemotherapy 30, 535-41.
3. Chavanet, P. Y., Garry, I., Charlier, N., Caillot, D., Kisterman, J. P., D'Athis, M. et al. (1992). Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis. British Medical Journal 305, 921-5.
4. Caillot, D., Reny, G., Solary, E., Casasnovas, O., Chavanet, P., Bonnette, B. et al. (1994). A controlled trial of the tolerance of amphotericin B infused in dextrose or in Intralipid in patients with haematological malignancies. Journal of Antimicrobial Chemotherapy 33, 603-13.
5. Chavanet, P., Charlier, N., Brenet, A., Goux, A., Muggéo, E., Caillot, D. et al. (1992). Emulsion de l'amphotéricine B dans I'Intralipide 20%: éfficacité in vitro et in vivo. Pathologie Biologie 40, 507-12.
6. Walsh, T. J., Garrett, K., Feuerstein, E., Girton, M., Allende, M., Bacher, J. et al. (1995). Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy. Antimicrobial Agents and Chemotherapy 39, 1065-9.
7. Scherrer, B. (1984). In Biostatistique (Morin, G., Ed.). Chicoutimi, Quebec, Canada.
8. Buisson, J. C., Charlier, N., Chavanet, P., Brunet, A., Caillot, D., Casasnovas, R. O. et al. (1992). Influence of intralipid on the in vitro efficacy of amphotericin-deoxycholate (AMB, Fungizone). In Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, 1992. Abstract 1607, p. 378. American Society for Microbiology, Washington, DC.
9. Godder, K., Parrish, R., Carr, D., Pati, A., Abhyankar, S., O'Neal, W. et al. (1995). Amphotericin in Intralipid is well tolerated and effective post bone marrow transplant. Blood 86, Suppl. 1, 947a.
10. Macedo, M. C. M. A., Dulley, F. L., Ostronoff, M., Machado, C. M., Zambon, E., Matsumoto, C. et al. (1994). Effectiveness of amphotericin B in lipid emulsion for treating fungal septicemia in granulocytopenic patients. Clinical Infectious Diseases 19, 366-7.
11. Lance, M. R., Washington, C. & Davis, S. S. (1995). Structure and toxicity of amphotericin B/triglyceride emulsion formulations. Journal of Antimicrobial Chemotherapy 36, 119-28.